Elevance Health Reaffirms 2026 Adjusted Earnings Of At Least $25.50 Per Share
ReutersFeb 26, 2026 8:03 PM
Feb 26 (Reuters) - Elevance Health Inc ELV.N:
ELEVANCE HEALTH - REAFFIRMS 2026 EARNINGS GUIDANCE OF AT LEAST $22.30 PER SHARE - SEC FILING
ELEVANCE HEALTH - EXPECTS 2026 ADJUSTED EARNINGS OF AT LEAST $25.50 PER SHARE - SEC FILING
Source text: [ID:n0001156039-26-000019]
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Tesla Steps Up China Market Promotions; Can EV Business Bottom Out and Rebound?
TradingKey - On February 26 local time, Tesla (TSLA) China announced that for orders placed by March 31, select models will be eligible for 7-year ultra-low interest and 5-year zero-interest financing plans, as well as insurance subsidies.TradingKey
13 hours ago
Has Beating Expectations Become the Norm? Nvidia Delivers Strong Q4 Results Again, but Market Remains Cautious?
TradingKey - Nvidia (NVDA) reported fourth-quarter results on Wednesday that beat expectations across the board, with its core data center business revenue surging 75% year-over-year to become the primary growth engine.TradingKey
16 hours ago
Nvidia Q4 Earnings: Market Fears Competition, but NVDA Moat is Beyond CUDA
All eyes are on Nvidia this week, as the company reports its 2026Q4 earnings.TradingKey
Wed, Feb 25
Nvidia Q4 Earnings Preview: AI-Driven Growth Versus Market Expectations
TradingKey - NVIDIA (NVDA) is set to release its fourth quarter fiscal year 2026 earnings report after the market close on February 25, ET. As the world undergoes a period of rapid AI technological advancement, market debates over a capital expenditure bubble have intensified. In this context, NVIDIA’s results serve not only as a test of its business performance but also as a core bellwether for the sustainability of the global AI boom.TradingKey
Tue, Feb 24
